Parathyroid hormone in blood pressure and volume homeostasis in healthy subjects, hyperparathyroidism, liver cirrhosis and glomerulonephritis. A possible interaction with angiotensin II and atrial natriuretic peptide

References

• Nussbaum S R, Zahradnik R J, Lavigne J R, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987; 33: 1364–8
   PubMed Web of Science ®Google Scholar
• Resnick L M. Calcium metabolism in hypertension and allied metabolic disorders. Diabetes Care 1991; 14: 505–20
   PubMed Web of Science ®Google Scholar
• Jones D B, Jones J H, Lloyd H J, Lucas P A, Wilkins W E, Walker D A. Changes in blood pressure and renal function after parathyroidectomy in primary hyperparathyroidism. Postgrad Med J 1983; 59: 350–3
   PubMed Web of Science ®Google Scholar
• Jespersen B, Brock A, Charles P, Danielsen H, Sørensen S S, Pedersen E B. Unchanged noradrenaline reactivity and blood pressure after corrective surgery in primary hyperparathyroidism. Scand J Clin Lab Invest 1993; 53: 479–86
   PubMedGoogle Scholar
• Jespersen B, Dam Jensen J, Brock A, Pedersen E B. Atrial natriuretic peptide and parathyroid hormone (1–84) in relation to noradrenaline induced changes in blood pressure in uraemic and healthy subjects. Scand J Urol Nephrol 1992; 26: 269–74
   PubMed Web of Science ®Google Scholar
• Jespersen B, Pedersen E B, Christensen N H, Danielsen H, Sørensen S S. Reduced angiotensin II induced vascular reactivity in chronic renal failure. Scand J Clin Lab Invest 1988; 48: 705–13
   PubMedGoogle Scholar
• Jespersen B, Pedersen E B, Charles P, Danielsen H, Juhl H. Elevated angiotensin II and vasopressin in primary hyperparathyroidism. Angiotensin II infusion studies before and after removal of the parathyroid adenoma. Acta Endocrinol 1989; 120: 362–8
   PubMedGoogle Scholar
• Jespersen B, Pedersen E B. Increased Plasma levels of atrial natriurtic peptide in patients with chronic renal failure–Effect of noradrenaline infusion. Nephrology Dialysis Transplantation 1988; 3: 762–7
   PubMed Web of Science ®Google Scholar
• Jespersen B, Jensen L, Sorensen S S, Pedersen E B. Atrial natriuretic factor, cyclic guanosine monophosphate and prostaglandin E2 in liver cirrhosis– relation to blood volume and changes in blood volume after furosemide. Eur J Clin Invest 1990; 20: 632–41
   PubMedGoogle Scholar
• Jespersen B, Sorensen S S, Pedersen E B. Effect of furosemide on atrial natriuretic peptide, guanosine cyclic monophosphate, angiotensin II, aldosterone, vasopressin prostaglandin E2 and blood volume in the nephrotic syndrome. Nephrol Dialysis Transplantation 1991; 6: 402–9
   PubMedGoogle Scholar
• Jespersen B, Danielsen H, Pedersen E B. Atrial natriuretic peptide and blood volume in patients with chronic glomerulonephritis–effects of albumin and furosemide administration. Nephrol Dial Transplantation 1990; 5: 997–1006
   PubMedGoogle Scholar
• Kappelgaard A M, Damjaer-Nielsen M, Giese J. Measurement of angiotensin II in human plasma: technical modification and practical experience. Clin Chim Acta 1976; 67: 299–306
   PubMed Web of Science ®Google Scholar
• Thomassen A, Bagger J P, Nielsen T T, Pedersen E B. Atrial natriuretic peptide during pacing in controls and patients with coronary artery disease. Int J Cardiol 1987; 17: 267–76
   PubMed Web of Science ®Google Scholar
• Campese V M. Calcium, parathyroid hormone and blood pressure. Am J Hypertens 1989; 2: 34S–44S
   PubMed Web of Science ®Google Scholar
• Neuser D, Schulte-Brinkmann R, Knorr A, Kazda S. Long-term hypotensive effect of parathyroid hormone in stroke prone spontaneously hypertensive rats. Eur J Pharmacol 1990; 182: 569–71
   PubMedGoogle Scholar
• Imaoka M, Morimoto S, Kitano S, Fukuo F, Ogi-Hara T. Calcium metabolism in elderly hypertensive patients: possible participation of exaggerated sodium, calcium and phosphate excretion. Clin Exp Pharmacol Physiol 1991; 18: 631–41
   PubMed Web of Science ®Google Scholar
• Berthelot A, Gairand A. Parathyroid hormone-and deoxycorticosterone acetate induced hypertension in the rat. Clin Sci 1980; 58: 365–371
   PubMed Web of Science ®Google Scholar
• Grant F D, Mandel S J, Brown E M, Williams G H, Seely E W. Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. J Clin Endocrinol Metab 1992; 75: 988–92
   PubMed Web of Science ®Google Scholar
• Habener J F, Rosenblatt M, Potts J T. Parathyroid hormone: Biochemical aspects of biosynthesis, secretion, action and metabolism. Physiol Rev 1984; 64: 985–1053
   PubMed Web of Science ®Google Scholar
• Body J-J, Cryer P E, Offord K P, Heath H. Epinephrine is a hypophosphatemic hormone in man. Physiological effects of circulating epinepphrine on plasma calcium, magnesium, phosphorus, parathyroid hormone and calcitonin. J Clin Invest 1983; 71: 572–8
   PubMedGoogle Scholar
• Awazu M, Ichikawa I. Biological significance of atrial natriuretic peptide in the kidney. Nephron 1993; 63: 1–14
   PubMedGoogle Scholar
• Jespersen B, Eiskjaer H, Pedersen E B. Effect of atrial natriuretic peptide on blood pressure, guano-sine 3′:5′-cyclic monophosphate release and blood volume in uraemic patients. Clin Sci 1990; 78: 67–73
   Web of Science ®Google Scholar
• Mann J FE, Wiecek A, Bommer J, Ganten U, Ritz E. Effects of parathyroidectomy on blood pressure in spontaneously hypertensive rats. Nephron 1987; 45: 46–52
   PubMedGoogle Scholar
• Knox F G, Schneider E G, Willis L R, et al. Proximal tubule reabosrption after hyperoncotic albumin infusion. J Clin Invest 1974; 53: 501–7
   PubMedGoogle Scholar
• Geiger H, Bahner U, Meissner M, et al. Parathyroid hormone modulates the release of atrial natriuretic peptide during acute volume expansion. Am J Nephrol 1992; 12: 259–64
   PubMedGoogle Scholar
• Petit W A, Henrich J, Insogna K L, Mitnick M E, Broadus A E. Influence of furosemide on parathyroid hormone levels in hyperparathyroidism. New Engl J Med 1988; 318: 644–5
   PubMedGoogle Scholar
• Bittar A E, Ratcliffe P J, Richardson A J, Brown R C, Woodhead J S, Morris P J. Hyperparathyroidism, hypertension and loop diuretic medication in renal transplant recipients. Nephrol Dial Transplant 1989; 4: 740–4
   PubMedGoogle Scholar
• Pang P KT, Hong B-S, Yen L, Yang M CM. Disturbances of some endocrine systems with vasoregulatory potential: Parathyroid hormone. Contr Nephrol. Karger, Basel 1984; 41: 137–45
   Google Scholar
• De Feo M L, Bartolini O, Orlando C, et al. Natriuretic peptide receptors regulate endothelin synthesis and release from parathyroid cells. Proc Natl Acad Sci USA 1991; 88: 6496–500
   PubMedGoogle Scholar
• Helwig J-J, Musso M-J, Judes C, Nickols G A. Parathyroid hormone and calcium: interactions in the control of renin secretion in the isolated, non-filtering rat kidney. Endocrinology 1991; 129: 1233–42
   PubMedGoogle Scholar
• Isales C M, Barrett P Q, Brines M, Bollag W, Rasmussen H. Parathyroid hormone modulates angiotensin II-induced aldosterone secretion from the adrenal glomerulosa cell. Endocrinology 1991; 129: 489–95
   PubMedGoogle Scholar
• Ø1gaard K, Daugaard H, Egfjord M. Parathyroid hormone enhances the stimulatory effect of Ca++ on aldosterone secretion. Kidney Int 1986; 29: 168A
   Google Scholar
• Lipkowitz M S, London R D, Beck J C, Abramson R G. Hormonal regulation of rat renal proximal tubule brush-border membrane ionic permeability. Am J Physiol 1992; 263: F144–51
   Google Scholar
• Ribeiro C P, Mandel L J. Parathyroid hormone inhibits proximal tubule Na+-K+-ATPase activity. Am J Physiol 1992; 262: F209–16
   Google Scholar
• Pearcé P C, Hawkey C, Symons C, Olsen E GJ. Role of calcium in the induction of cardiac hypertrophy and myofibrillar disarray Experimental studies of a possible cause of hypertrophic cardiomyopathy. Br Heart J 1985; 54: 420–7
   PubMedGoogle Scholar